Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer.

MLA

Pchejetski, Dmitri, et al. “Histone Deacetylases as New Therapy Targets for Platinum-Resistant Epithelial Ovarian Cancer.” Journal of Cancer Research & Clinical Oncology, vol. 142, no. 8, Aug. 2016, pp. 1659–71. EBSCOhost, https://doi.org/10.1007/s00432-015-2064-5.

APA

Pchejetski, D., Alfraidi, A., Sacco, K., Alshaker, H., Muhammad, A., & Monzon, L. (2016). Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer. Journal of Cancer Research & Clinical Oncology, 142(8), 1659–1671. https://doi.org/10.1007/s00432-015-2064-5

Chicago

Pchejetski, Dmitri, Albandri Alfraidi, Keith Sacco, Heba Alshaker, Aun Muhammad, and Leonardo Monzon. 2016. “Histone Deacetylases as New Therapy Targets for Platinum-Resistant Epithelial Ovarian Cancer.” Journal of Cancer Research & Clinical Oncology 142 (8): 1659–71. doi:10.1007/s00432-015-2064-5.